Marisol Quintero is the founder of Highlight Therapeutics. Highlight Therapeutics has raised $49M in total funding. Latest round: Series B.
Marisol Quintero is the CEO of Highlight Therapeutics, a clinical-stage biopharmaceutical company based in Valencia, Spain, focused on immuno-oncology therapies for skin tumors and RNA-based treatments. She leads the company as it advances BO-112 through multiple clinical trials. Quintero has been instrumental in securing over €45 million in cumulative funding.
Full founder directory · Investor directory · Company funding database · Fundraising library